Instrumentum Acquires cultivate(MD)'s Portfolio Company

June 11, 2025
cultivate(MD), a medical device venture capital company, had their portfolio acquired by Instrumentum, a company specializing in surgical instrument sterilization services.

cultivate(MD) has announced that its portfolio company, Sterile Processing Express (SDPx), was acquired by Instrumentum, LLC. PR Newswire has the press release.

cultivate(MD) is a medical device venture capital company, and Instrumentum is a company that specializes in surgical instrument sterilization services. This acquisition will expand “Instrumentum's operational footprint to five facilities across four states, significantly enhancing its capacity to meet the increasing demand for offsite sterile processing driven by the continued rise in elective surgeries at hospitals, clinics, and ambulatory surgery centers (ASCs).”

The transaction also “marks a successful outcome for SPDx's sterile processing model, validating cultivate(MD)'s early investment thesis. As part of Instrumentum, SPDx's operational capabilities will now integrate with a scalable commercial platform, accelerating nationwide expansion and increasing value across the surgical care ecosystem.”

Matt Ahearn, the director at cultivate(MD), said that this transaction “represents a strategic move that enables the facility launch, quality, and operational expertise of SPDx, to be integrated with the commercial strategy of Instrumentum, ensuring that combined efforts of both teams maximize the potential of this market opportunity.”

About the Author

Matt MacKenzie | Associate Editor

Matt is Associate Editor for Healthcare Purchasing News.

ID 78258398 © Tashatuvango | Dreamstime.com
dreamstime_xxl_78258398
ID 33129254 © Pressureua | Dreamstime.com
dreamstime_xxl_33129254
ID 23231471 © Artistashmita | Dreamstime.com
dreamstime_xxl_23231471
View from the Galt House
img_4619
ID 104675639 © Mohd Hafiez Mohd Razali | Dreamstime.com
dreamstime_xl_104675639